SCHEMBL7830848

SCHEMBL7830848

Fc1ccc(N2CCNCC2)c(-c2ncco2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 2/20 0.47
HTR7 P34969 4/20 0.45
ADRA2A P08913 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1B P35368 1/20 0.44
HCRTR1 O43613 2/20 0.42
HCRTR2 O43614 2/20 0.42
ADRB2 P07550 2/20 0.42
NCF1 P14598 2/20 0.42
ACVR1 Q04771 1/20 0.41
KDR P35968 1/20 0.40
HTR1A P08908 3/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
HTR6 P50406 4/20 0.39
HTR2B P41595 2/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7830123 0.81 HTR7 (0.58) HTR7ADRB2NCF1HTR1ASLC6A2
SCHEMBL29639915 0.76 KCNH2 (0.43) HTR7ADRB2NCF1HTR1AHTR6
SCHEMBL8226116 0.76 KCNH2 (0.43) HTR7ADRB2NCF1HTR1AHTR6
SCHEMBL29639951 0.73 HTR7 (0.44) HTR7ADRB2NCF1HTR1AHTR6
SCHEMBL29557426 0.70 KDR (0.53) HTR7KDRHTR1ASLC6A2SLC6A4
SCHEMBL233938 0.70 KDR (0.53) HTR7KDRHTR1ASLC6A2SLC6A4
SCHEMBL30059007 0.70 NCF1 (0.70) ADRB2NCF1KDRHTR6
SCHEMBL17729254 0.70 NCF1 (0.70) HTR7ADRB2NCF1KDRHTR1A
SCHEMBL5638528 0.70 NCF1 (0.70) ADRB2NCF1KDRHTR6
SCHEMBL31039212 0.69 ADRA1A (0.47) ADRA1AADRA2AADRA1DADRA1BHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed